Wednesday, July 8, 2026

pharma · Lupus Nephritis · Generalized Myasthenia Gravis · AUPH

Aurinia Pharmaceuticals

Aurinia Pharmaceuticals clinical programs — 14 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

1196 Hwy 3 South, Northfield, MN 55057, US HQ
2007 Founded
81 Employees
Public company Type
AUPH · NYSE Ticker
Company details
Status
Public
HQ
1196 Hwy 3 South, Northfield, MN 55057, US
Founded
2007
Employees
81
Programs
14
Drugs
10
Patents
7
Intelligence · Clinical Programs

Aurinia Pharmaceuticals projects

14 ClinicalTrials.gov programs sponsored by Aurinia Pharmaceuticals.

Aurinia Pharmaceuticals has 14 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. 0.05% Voclosporin Ophthalmic Solution (VOS)

    Aurinia Pharmaceuticals

    Dry Eye Syndrome

    phase 3 small molecule completed

    1 trial
  2. Voclosporin

    Aurinia Pharmaceuticals

    Lupus Nephritis

    phase 3 small molecule completed

    3 trials
  3. Voclosporin

    Aurinia Pharmaceuticals

    Adolescent Lupus Nephritis

    phase 3 small molecule terminated

    2 trials
  4. voclosporin

    Aurinia Pharmaceuticals

    Psoriasis

    phase 3 small molecule completed

    3 trials
  5. voclosporin

    Aurinia Pharmaceuticals

    Renal Transplantation

    phase 3 small molecule terminated

    1 trial
  6. AUR-200-2024-02

    Aurinia Pharmaceuticals

    Generalized Myasthenia Gravis

    phase 2 small molecule active

    1 trial
  7. Aritinercept

    Aurinia Pharmaceuticals

    Myasthenia Gravis, Generalized

    phase 2 small molecule active

    1 trial
  8. Voclosporin

    Aurinia Pharmaceuticals

    Covid19

    phase 2 small molecule completed

    1 trial
  9. Voclosporin

    Aurinia Pharmaceuticals

    Focal Segmental Glomerulosclerosis

    phase 2 small molecule terminated

    1 trial
  10. Voclosporin

    Aurinia Pharmaceuticals

    Kidney Diseases

    phase 2 small molecule completed

    1 trial
  11. Voclosporin High Dose

    Aurinia Pharmaceuticals

    Lupus Nephritis

    phase 2 small molecule completed

    1 trial
  12. Voclosporin Ophthalmic Solution

    Aurinia Pharmaceuticals

    Dry Eye

    phase 2 small molecule completed

    1 trial
  13. Simvastatin

    Aurinia Pharmaceuticals

    Drug-drug Interaction

    phase 1 small molecule completed

    1 trial
  14. Voclosporin

    Aurinia Pharmaceuticals

    Volunteers

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Aurinia Pharmaceuticals have?

14 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.